The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America
Abstract Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally teste...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e2a46466c457485ebccc0a5a231ac943 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:e2a46466c457485ebccc0a5a231ac943 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:e2a46466c457485ebccc0a5a231ac9432021-12-02T18:51:05ZThe shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America10.1038/s41541-021-00380-x2059-0105https://doaj.org/article/e2a46466c457485ebccc0a5a231ac9432021-09-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00380-xhttps://doaj.org/toc/2059-0105Abstract Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how five features of mass vaccination campaigns—the vaccine’s producer, efficacy, endorser, distributor, and current population uptake rate—shifted willingness to take a COVID-19 vaccine. We find that citizens preferred Western-produced vaccines, but were highly influenced by factual information about vaccine efficacy. Vaccine hesitant individuals were more responsive to vaccine messengers with medical expertise than political, religious, or media elite endorsements. Citizen trust in foreign governments, domestic leaders, and state institutions moderated the effects of the campaign features on vaccine acceptance. These findings can help inform the design of unfolding mass inoculation campaigns.Pablo ArgoteElena BarhamSarah Zukerman DalyJulian E. GerezJohn MarshallOscar PocasangreNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Pablo Argote Elena Barham Sarah Zukerman Daly Julian E. Gerez John Marshall Oscar Pocasangre The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America |
| description |
Abstract Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how five features of mass vaccination campaigns—the vaccine’s producer, efficacy, endorser, distributor, and current population uptake rate—shifted willingness to take a COVID-19 vaccine. We find that citizens preferred Western-produced vaccines, but were highly influenced by factual information about vaccine efficacy. Vaccine hesitant individuals were more responsive to vaccine messengers with medical expertise than political, religious, or media elite endorsements. Citizen trust in foreign governments, domestic leaders, and state institutions moderated the effects of the campaign features on vaccine acceptance. These findings can help inform the design of unfolding mass inoculation campaigns. |
| format |
article |
| author |
Pablo Argote Elena Barham Sarah Zukerman Daly Julian E. Gerez John Marshall Oscar Pocasangre |
| author_facet |
Pablo Argote Elena Barham Sarah Zukerman Daly Julian E. Gerez John Marshall Oscar Pocasangre |
| author_sort |
Pablo Argote |
| title |
The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America |
| title_short |
The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America |
| title_full |
The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America |
| title_fullStr |
The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America |
| title_full_unstemmed |
The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America |
| title_sort |
shot, the message, and the messenger: covid-19 vaccine acceptance in latin america |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/e2a46466c457485ebccc0a5a231ac943 |
| work_keys_str_mv |
AT pabloargote theshotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT elenabarham theshotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT sarahzukermandaly theshotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT julianegerez theshotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT johnmarshall theshotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT oscarpocasangre theshotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT pabloargote shotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT elenabarham shotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT sarahzukermandaly shotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT julianegerez shotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT johnmarshall shotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica AT oscarpocasangre shotthemessageandthemessengercovid19vaccineacceptanceinlatinamerica |
| _version_ |
1718377476510449664 |